Initial versus recent outcomes with a non-risk adapted surveillance policy in stage I non-seminomatous germ cell tumors (NSGCT)

被引：0
|
作者：
Duran, I. [1 ]
Sturgeon, J. F. [1 ]
Jewett, M. A. [1 ]
Anson-Cartwright, L. [1 ]
Berthold, D. R. [1 ]
Kakiashvili, D. [1 ]
Warde, P. R. [1 ]
Alison, R. E. [1 ]
Pond, G. R. [1 ]
Moore, M. J. [1 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5021
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Laparoscopic lumboaortic lymphadenectomy in early stage non-seminomatous germ cell tumours (NSGCT) of the testis: Why and how?
    Leblanc, E
    Caty, A
    Dargent, D
    Querleu, D
    Mazeman, E
    PROGRES EN UROLOGIE, 2000, 10 (03): : 379 - 387
  • [42] Clinical evaluation of Olympus AFP assay as an aid in the management of patients with non-seminomatous germ cell tumors (NSGCT)
    Shah, H.
    Rush, C.
    Minihan, M.
    Kenny, P.
    Davis, D.
    Loebel, J.
    Lepp, C.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A111 - A112
  • [43] Testicular non-seminomatous germ cell tumors (NSGCT) and brain metastases: About a rare location of the posterior fossa
    Borni, Mehdi
    Kolsi, Fatma
    Kammoun, Brahim
    Kallel, Rim
    Souissi, Ghassen
    Boudawara, Mohamed Zaher
    UROLOGY CASE REPORTS, 2018, 21 : 61 - 63
  • [44] Approach to chemotherapy for high-risk, stage 1, non-seminomatous, germ cell testicular tumors
    Anand, Madhur
    INDIAN JOURNAL OF UROLOGY, 2021, 37 (02) : 197 - 198
  • [45] TREATMENT OF NON-SEMINOMATOUS GERM-CELL TUMORS OF TESTIS
    BRINKLEY, D
    PRYOR, JP
    LANCET, 1983, 1 (8319): : 298 - 298
  • [46] Resection of post-chemotherapy residual masses (RMs) in patients with advanced non-seminomatous germ cell tumors (NSGCT): prediction of outcomes
    Mediano Rambla, M.
    Thiery-Vuillemin, A.
    Alonso, M.
    Ocon, E.
    Conde, M.
    Sancho, P.
    Osman, I.
    Robles, C.
    Medina, R.
    Duran, I.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S650 - S650
  • [47] Clinical outcomes in patients with post-chemotherapy residual non-retroperitoneal (RP) disease in non-seminomatous germ-cell tumors (NSGCT)
    King, Jennifer
    Ashkar, Ryan
    Kesler, Kenneth
    Althouse, Sandra K.
    Hanna, Nasser H.
    Einhorn, Lawrence H.
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] SURVEILLANCE FOR STAGE-I NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - THE OPTIMAL PROTOCOL HAS NOT YET BEEN DEFINED
    RAGHAVAN, D
    COLLS, B
    LEVI, J
    FITZHARRIS, B
    TATTERSALL, MHN
    ATKINSON, C
    WOODS, R
    COOREY, G
    FARRELL, C
    WINES, R
    BRITISH JOURNAL OF UROLOGY, 1988, 61 (06): : 522 - 526
  • [49] Contemporary treatment of low risk stage I non-seminomatous germ cell testicular tumors: A survey of the Society of Urologic Oncology
    Alanee, Shaheen
    Nicholson, Adam
    Slaton, Joel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (06) : 749 - 751
  • [50] Risk factors for relapse in stage I non-seminomatous germ-cell tumors: Preliminary results of the German Multicenter Trial
    Albers, P
    Siener, R
    Hartmann, M
    Weinknecht, S
    Schulze, H
    Rebmann, U
    Kuczyk, M
    deRiese, W
    Loy, V
    Bierhoff, E
    Wittekind, C
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (06) : 828 - 830
12345